# EDGAR Filing Document

**Accession Number:** 0001964933
**File Stem:** 0001127602-23-003927
**Filing Date:** 2023-2
**Character Count:** 10955
**Document Hash:** c613b003d5230162b09923f947d2f14c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001127602-23-003927.hdr.sgml**: 20230208

**ACCESSION NUMBER**: 0001127602-23-003927

**CONFORMED SUBMISSION TYPE**: 3

**PUBLIC DOCUMENT COUNT**: 2

**CONFORMED PERIOD OF REPORT**: 20230201

**FILED AS OF DATE**: 20230208

**DATE AS OF CHANGE**: 20230208

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Gajewski Kristen
- **CENTRAL INDEX KEY:** 0001964933

**FILING VALUES:**
- **FORM TYPE:** 3
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-16091
- **FILM NUMBER:** 23597572

**MAIL ADDRESS:**
- **STREET 1:** 33587 WALKER ROAD
- **CITY:** AVON LAKE
- **STATE:** OH
- **ZIP:** 44012
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** AVIENT CORP
- **CENTRAL INDEX KEY:** 0001122976
- **STANDARD INDUSTRIAL CLASSIFICATION:** PLASTICS, MATERIALS, SYNTH RESINS & NONVULCAN ELASTOMERS [2821]
- **IRS NUMBER:** 341730488
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 33587 WALKER ROAD
- **CITY:** AVON LAKE
- **STATE:** OH
- **ZIP:** 44012
- **BUSINESS PHONE:** 440-930-1000

**MAIL ADDRESS:**
- **STREET 1:** 33587 WALKER ROAD
- **CITY:** AVON LAKE
- **STATE:** OH
- **ZIP:** 44012

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** POLYONE CORP
- **DATE OF NAME CHANGE:** 20000830

## Ex-24

```

Power of Attorney

       Know all by these presents that the undersigned hereby constitutes and
appoints each of Robert M. Patterson, Jamie A. Beggs and Lisa K.
Kunkle, signing singly, the undersigned's true and lawful attorney-in-fact
to:

1.	Prepare, execute in the undersigned's name and on the undersigned's
behalf, and submit to the U.S. Securities and Exchange Commission (the
"SEC") a Form ID, including amendments thereto, and any other documents
necessary or appropriate to obtain codes and passwords enabling the
undersigned to make electronic filings with the SEC of reports required
by Section 16(a) of the Securities Exchange Act of 1934 or any rule or
regulation of the SEC; and

2.	Execute for and on behalf of the undersigned, in the
undersigned's capacity as an officer and/or director of PolyOne
Corporation (the "Corporation"), Forms 3, 4, and 5 in accordance
with Section 16(a) of the Securities Exchange Act of 1934 and the
rules thereunder; and

3.	Do and perform any and all acts for and on behalf of the
undersigned which may be necessary or desirable to complete and
execute any such Form 3, 4, or 5 and timely file such form with
the SEC and any stock exchange or similar authority; and

4.	Take any other action of any type whatsoever in connection with
the foregoing which, in the opinion of such attorney-in-fact, may
be of benefit to, in the best interest of, or legally required
by, the undersigned, it being understood that the documents
executed by such attorney-in-fact on behalf of the undersigned
pursuant to this Power of Attorney shall be in such form and
shall contain such terms and conditions as such attorney-in-fact
may approve in such attorney-in-fact's discretion.

       The undersigned hereby grants to each such attorney-in-fact full power
and authority to do and perform any and every act and thing whatsoever
requisite, necessary, or proper to be done in the exercise of any of the
rights and powers herein granted, as fully to all intents and purposes as the
undersigned might or could do if personally present, with full power of
substitution or revocation, hereby ratifying and confirming all that such
attorney-in-fact, or such attorney-in-fact's substitute or substitutes, shall
lawfully do or cause to be done by virtue of this power of attorney and the
rights and powers herein granted.  The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving in such capacity at the request of
the undersigned, are not assuming, nor is the Corporation assuming, any of
the undersigned's responsibility to comply with Section 16 of the Securities
Exchange Act of 1934.

	This Power of Attorney shall remain in full force and effect until the
undersigned is no longer required to file Forms 3, 4, and 5 with respect to
the undersigned's holdings of and transactions in securities issued by the
Corporation, unless earlier revoked by the undersigned in a signed writing
delivered to the foregoing attorneys-in-fact.

	IN WITNESS WHEREOF, the undersigned has caused this Power of Attorney
to be executed as of this 18th day of January 2023.

								/s/ Kristen Gajewski
       ____________________________
								Kristen Gajewski

```

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3

### INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Gajewski Kristen<br><sub>(Last) (First) (Middle)</sub><br>AVIENT CENTER<br><sub>(Street)</sub><br>AVON LAKE, OH 44012<br><sub>(City) (State) (Zip)</sub> | **3. Issuer Name and Ticker or Trading Symbol**<br>AVIENT CORP [ AVNT ] | **5. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  |
| **2. Date of Event Requiring Statement (Month/Day/Year)**<br>2023-02-01 | **4. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director   [ ] 10% Owner<br>[X] Officer (give title below)   [ ] Other (specify below)<br>_SVP & CHRO_ | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities Beneficially Owned

---

|  |  |  |  |
| --- | --- | --- | --- |
| 1. Title of Security | 2. Amount of Securities Beneficially Owned | 3. Ownership Form | 4. Nature of Indirect Beneficial Ownership |
| Common Stock | 929 | D |  |
| Common Stock | 840.407 | I | Savings Plan Trust<sup>(1)</sup> |
| Common Stock | 95.234 | I | Supplemental Plan<sup>(1)</sup> |

---

## Table II - Derivative Securities Beneficially Owned

---

|  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Underlying Securities | 3. Title and Amount of Underlying Securities | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 4. Conversion or Exercise Price | 5. Ownership Form | 6. Nature of Indirect Beneficial Ownership |
| Restricted Stock Units | <sup>(2)</sup> | 2023-02-10 | Common Stock | 769<sup>(3)</sup> | <sup>(2)</sup> | D |  |
| Restricted Stock Units | <sup>(4)</sup> | 2024-02-08 | Common Stock | 670<sup>(3)</sup> | <sup>(4)</sup> | D |  |
| Restricted Stock Units | <sup>(5)</sup> | 2025-02-14 | Common Stock | 668<sup>(3)</sup> | <sup>(5)</sup> | D |  |
| Stock Appreciation Rights | <sup>(6)</sup> | 2028-02-14 | Common Stock | 1150 | $41.89 | D |  |
| Stock Appreciation Rights | <sup>(7)</sup> | 2029-02-11 | Common Stock | 700 | $31.54 | D |  |
| Stock Appreciation Rights | <sup>(8)</sup> | 2030-02-10 | Common Stock | 1466 | $31.48 | D |  |
| Stock Appreciation Rights | <sup>(9)</sup> | 2031-02-08 | Common Stock | 2570 | $42.27 | D |  |
| Stock Appreciation Rights | <sup>(10)</sup> | 2032-02-11 | Common Stock | 2300 | $52.64 | D |  |

---

### Footnotes:

(1) The information in this report is based on a plan statement as of February 1, 2023.

(2) The restricted stock units vest 3 years from the date of grant on February 10, 2023.

(3) The restricted stock units include all dividend equivalents acquired since the date of grant.  Dividend equivalents are subject to the same restrictions as the underlying grant of restricted stock units.

(4) The restricted stock units vest 3 years from the date of grant on February 8, 2024.

(5) The restricted stock units vest 3 years from the date of grant on February 14, 2025.

(6) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $41.89 per share and no more than one-third of the grant can vest per year during the first three years.

(7) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.54 per share and no more than one-third of the grant can vest per year during the first three years.

(8) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $31.48 per share and no more than one-third of the grant can vest per year during the first three years.

(9) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $42.27 per share and no more than one-third of the grant can vest per year during the first three years.

(10) SARs become exercisable and vest only upon the achievement of both price and time requirements. To vest, each one-third of the grant must attain 10%, 15% and 20% stock appreciation, respectively (which must be maintained for a minimum of thirty consecutive trading days) from the grant date closing price of $52.64 per share and no more than one-third of the grant can vest per year during the first three years.

**Signature:** /s/ Lisa K. Kunkle, Power of Attorney For: Kristen Gajewski  
**Date:** 2023-02-08

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**